FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....